Bridgewater Associates’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.68M | Sell |
26,410
-6,589
| -20% | -$2.37M | 0.04% | 294 |
|
|
2025
Q4 | $11.6M | Buy |
32,999
+20,897
| +173% | +$7.61M | 0.04% | 320 |
|
|
2025
Q3 | $4.47M | Buy |
12,102
+235
| +2% | +$90.8K | 0.02% | 516 |
|
|
2025
Q2 | $4.69M | Sell |
11,867
-3,617
| -23% | -$1.35M | 0.02% | 337 |
|
|
2025
Q1 | $5.76M | Sell |
15,484
-24,381
| -61% | -$9.28M | 0.03% | 333 |
|
|
2024
Q4 | $14.4M | Sell |
39,865
-19,373
| -33% | -$7.18M | 0.07% | 209 |
|
|
2024
Q3 | $21.4M | Sell |
59,238
-247,566
| -81% | -$85.5M | 0.12% | 149 |
|
|
2024
Q2 | $104M | Sell |
306,804
-23,084
| -7% | -$7.82M | 0.55% | 35 |
|
|
2024
Q1 | $118M | Sell |
329,888
-75,160
| -19% | -$25.3M | 0.6% | 37 |
|
|
2023
Q4 | $121M | Sell |
405,048
-8,471
| -2% | -$2.38M | 0.68% | 30 |
|
|
2023
Q3 | $113M | Buy |
413,519
+27,782
| +7% | +$7.97M | 0.68% | 28 |
|
|
2023
Q2 | $118M | Sell |
385,737
-37,477
| -9% | -$10.8M | 0.73% | 26 |
|
|
2023
Q1 | $121M | Sell |
423,214
-82,798
| -16% | -$22M | 0.74% | 24 |
|
|
2022
Q4 | $124M | Sell |
506,012
-103,216
| -17% | -$23.4M | 0.68% | 23 |
|
|
2022
Q3 | $123M | Sell |
609,228
-19,813
| -3% | -$4.17M | 0.62% | 29 |
|
|
2022
Q2 | $125M | Buy |
629,041
+76,814
| +14% | +$18M | 0.53% | 30 |
|
|
2022
Q1 | $148M | Buy |
552,227
+139,070
| +34% | +$36M | 0.6% | 25 |
|
|
2021
Q4 | $110M | Buy |
413,157
+22,861
| +6% | +$6M | 0.64% | 27 |
|
|
2021
Q3 | $103M | Buy |
390,296
+74,538
| +24% | +$19.9M | 0.56% | 29 |
|
|
2021
Q2 | $82M | Buy |
315,758
+126,039
| +66% | +$32.2M | 0.53% | 37 |
|
|
2021
Q1 | $46.2M | Buy |
189,719
+815
| +0.4% | +$195K | 0.41% | 49 |
|
|
2020
Q4 | $46.3M | Buy |
188,904
+98,064
| +108% | +$22.2M | 0.4% | 43 |
|
|
2020
Q3 | $18.9M | Buy |
90,840
+77,171
| +565% | +$15M | 0.23% | 50 |
|
|
2020
Q2 | $2.46M | Sell |
13,669
-6,377
| -32% | -$1.18M | 0.04% | 84 |
|
|
2020
Q1 | $3.34M | Buy |
+20,046
| New | +$3.92M | 0.07% | 88 |
|
|
2018
Q4 | – | Sell |
-9,239
| Closed | -$1.64M | – | 512 |
|
|
2018
Q3 | $1.64M | Buy |
+9,239
| New | +$1.58M | 0.02% | 188 |
|
|
2016
Q1 | – | Sell |
-12,164
| Closed | -$1.13M | – | 305 |
|
|
2015
Q4 | $1.13M | Buy |
+12,164
| New | +$1.16M | 0.01% | 216 |
|
|
2015
Q3 | – | Sell |
-65,733
| Closed | -$6.28M | – | 490 |
|
|
2015
Q2 | $6.28M | Buy |
65,733
+48,300
| +277% | +$4.58M | 0.06% | 85 |
|
|
2015
Q1 | $1.61M | Buy |
17,433
+5,592
| +47% | +$520K | 0.01% | 199 |
|
|
2014
Q4 | $1.12M | Buy |
11,841
+1,500
| +15% | +$133K | 0.01% | 242 |
|
|
2014
Q3 | $835K | Buy |
+10,341
| New | +$851K | 0.01% | 238 |
|
|
2014
Q2 | – | Sell |
-11,667
| Closed | -$951K | – | 366 |
|
|
2014
Q1 | $951K | Sell |
11,667
-1,900
| -14% | -$151K | 0.01% | 245 |
|
|
2013
Q4 | $1.02M | Sell |
13,567
-3,000
| -18% | -$219K | 0.01% | 208 |
|
|
2013
Q3 | $1.12M | Sell |
16,567
-6,433
| -28% | -$444K | 0.01% | 197 |
|
|
2013
Q2 | $1.49M | Buy |
+23,000
| New | +$1.53M | 0.01% | 172 |
|
Other funds holding SYK
VCM
GT
VPM
Bridgewater Associates's SYK Position: Q1 2026 in Review
Bridgewater Associates reduced its Stryker (SYK) stake by 20% in Q1 2026, selling an estimated $2.37M and leaving 26,410 shares worth $8.68M. The position accounts for 0.04% of the portfolio, ranked #294.
Bridgewater Associates first reported a position in SYK in Q2 2013 and has held it in 35 quarters since. The position peaked at $148M in Q1 2022. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.
- Bridgewater Associates held 26,410 shares of Stryker worth $8.68M as of Q1 2026.
- Bridgewater Associates sold 6,589 Stryker shares in Q1 2026, an estimated $2.37M.
- Stryker made up 0.04% of Bridgewater Associates's portfolio in Q1 2026, its #294 holding.
- Bridgewater Associates first reported a position in Stryker in Q2 2013 and has held it in 35 quarters since.
- Bridgewater Associates's Stryker position peaked at $148M in Q1 2022.
- 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.